Pallas Capital Advisors LLC Xeris Biopharma Holdings, Inc. Transaction History
Pallas Capital Advisors LLC
- $2.24 Billion
- Q1 2025
A detailed history of Pallas Capital Advisors LLC transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Pallas Capital Advisors LLC holds 15,343 shares of XERS stock, worth $67,662. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,343Holding current value
$67,662% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding XERS
# of Institutions
163Shares Held
60.9MCall Options Held
34.2KPut Options Held
21.7K-
Black Rock Inc. New York, NY10.3MShares$45.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.9MShares$34.8 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.35MShares$14.8 Million0.0% of portfolio
-
State Street Corp Boston, MA3.34MShares$14.7 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.88MShares$12.7 Million0.0% of portfolio
About Xeris Biopharma Holdings, Inc.
- Ticker XERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,956,992
- Market Cap $600M
- Description
- Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...